salicylamide


Also found in: Dictionary, Encyclopedia, Wikipedia.

salicylamide

 [sal″ĭ-sil´ah-mīd]
the amide of salicylic acid, a component of some over-the-counter analgesics and antipyretics.

sal·i·cyl·am·ide

(sal'i-sil'ă-mīd),
The amide of salicylic acid, o-hydroxybenzamide; an analgesic, antipyretic and antiarthritic, similar in action to aspirin.

salicylamide

/sal·i·cyl·amide/ (sal″ĭ-sil-am´īd) an amide of salicylic acid used as an analgesic and antipyretic.

sal·i·cyl·am·ide

(sal'i-sil'ă-mīd)
Amide of salicylic acid; an analgesic, antipyretic, and antiarthritic, similar in action to aspirin.

salicylamide (sal´isilam´īd),

n an analgesic, antipyretic, and antiarthritic similar in action to aspirin.

salicylamide

an amide of salicylic acid; used as an analgesic; toxic in cats.
References in periodicals archive ?
Caffeic acid, ferulic acid, DMSO, and assay substrates (dihydrodichlorofluorescein, rhodamine 123, nile red, 7-ethoxyresorufin, 7-benzyloxyresorufin, resorufin, H33258, salicylamide, dicumarol) were purchased from Sigma (St.
The efficiency of sulfation reactions can be compromised by temporary depletion of inorganic sulfate pools by ingestion of drugs such as salicylamide [67].
B) Fever Blister and Cold Sore Treatment Drug Products -- Allyl Isothiocyanate, Aspirin, Bismuth Sodium Tartrate, Camphor, Capsaicin, Capsicum, Capsicum Oleoresin, Chloral Hydrate, Chlorobutanol, Cyclomethycaine Sulfate, Eucalyptus Oil, Eugenol, Glycol Salicylate, Hexylresorcinol, Histamine Dihydrochloride, Menthol, Methapyrilene Hydrochloride, Methyl Nicotinate, Methyl Salicylate, Pectin, Salicylamide, Strong Ammonia Solution, Tannic Acid, Thymol, Tripelennamine Hydrochloride, Trolamine Salicylate, Turpentine Oil, Zinc Sulfate.
In addition, the report presents a preliminary draft of the human amniotic fluid metabolome from women with PTL that shows biochemical intermediates of human metabolism as well as xenobiotics such as salicylamide and bacterial products can be measured in human amniotic fluid.
Titled "In Vitro Characterization of the Neutralization of Low Molecular Weight Heparin and Heparin-Like Drugs by Novel Salicylamide Derivatives", "In Vivo Neutralization of Unfractionated Heparin and Low Molecular Weight Heparin by a Novel Salicylamide Derivative", and "Ex Vivo Neutralization of Enoxaparin in Primates by a Novel Heparin Antagonist", the posters described a series of laboratory and animal studies with various PolyMedix heptagonist compounds, including PMX-60056, and described their abilities to reverse the activities of low molecular weight heparin, fondaparinux, and unfractionated heparin.
The data will be presented in a poster on December 9, 2007, Abstract 1869, titled: "In Vitro Characterization of the Neutralization of Unfractionated Heparin and Low Molecular Weight Heparin by Novel Salicylamide Derivatives.